Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period.
Peter J WeidenYangchun DuChih-Chin LiuArielle D StanfordPublished in: CNS spectrums (2018)
Switching from an oral antipsychotic to AL was feasible in an outpatient setting for patients with schizophrenia, and the 12-week retention rate was favorable.
Keyphrases